These companies have a new chief executive or a new plan. The market waits for proof that the change works before it changes its view. Quarterly results show whether the plan is on track.
This is information, not advice (see the disclaimer).
Deep below intrinsic value · Analysts: Mixed
Investors worry that high prices and weight-loss drugs shrink candy volumes, so the gap closes slowly as cocoa costs fall and volumes stop falling, possibly not before 2028.
Next checkpoint: Full-year 2026 results and 2027 outlook (Jan 29, 2027 (estimate))
Far below intrinsic value · Analysts: Mixed
Investors see a long decline in Comcast's broadband business as fiber and wireless rivals cut prices, and smaller losses with a clean spin-off of NBCUniversal can close the gap slowly.
Next checkpoint: Full-year 2026 results and 2027 plan (Jan 22, 2027 (estimate))
Far below intrinsic value · Analysts: Bearish
The market prices Conagra for falling volumes and high debt, and stable volumes with lower leverage under the new CEO over the next two years can close the gap.
Next checkpoint: Q2 fiscal 2027 earnings: volumes and margin (Dec 30, 2026 (estimate))
Far below intrinsic value · Analysts: Bullish
Falling US profit, prediction markets, higher taxes and a new CEO hold Flutter down, so FanDuel must grow again and leverage must fall for the gap to close.
Next checkpoint: Brazil: Congress decision on the betting ban (Jan 2027 (estimate))
Far below intrinsic value · Analysts: Leaning bullish
Higher service costs, a weak China market and a CEO change hold the price down, and stable margins and a strong successor over three to five quarters can close the gap.
Next checkpoint: Full-year 2026 results and 2027 outlook (Jan 28, 2027 (estimate))
Far below intrinsic value · Analysts: Bullish
Investors fear that high fuel prices cut airline engine work while StandardAero changes its CEO, and steady growth and margins over three to five quarters can close the gap.
Next checkpoint: FY 2026 results and first guidance of the new CEO (Feb 5, 2027 (estimate))
Far below intrinsic value · Analysts: Bearish
Investors fear lasting damage from the sales drop and high debt, so the gap closes slowly, as sales recover, debt falls and a new CEO arrives through 2027.
Next checkpoint: Fiscal Q2 2027 earnings: margin repair and GOJO (Feb 2, 2027 (estimate))
Far below intrinsic value · Analysts: Bearish
Falling Americas sales, tariffs and a full change of leaders make investors doubt the lululemon brand, so the gap closes slowly, only if a new product line restores growth.
Next checkpoint: Q3 fiscal 2026 results: Americas sales (Dec 3, 2026 (estimate))
Well below intrinsic value · Analysts: Mixed
The market fears that AI tools will replace Adobe's paid creative seats, and the gap closes slowly only if ARR keeps growing at about ten percent under the new CEO.
Next checkpoint: Q4 FY2026 earnings and FY2027 targets (Dec 10, 2026 (estimate))
Well below intrinsic value · Analysts: Mixed
Investors doubt that CarMax's new CEO can grow sales without lower profit per car, and steady volume, cost cuts and stable loan losses over four to six quarters can close the gap.
Next checkpoint: Q3 fiscal 2027 results: volume and profit per car (Dec 17, 2026)
Well below intrinsic value · Analysts: Leaning bullish
Firewall sales fell after Check Point changed its sales model, and a return to product growth as new sellers ramp in the first half of 2027 can close the gap.
Next checkpoint: Full-year 2026 results and 2027 outlook (Feb 2, 2027 (estimate))
Well below intrinsic value · Analysts: Leaning bullish
Investors doubt the payoff from Homes.com and fear AI search, and steady profit growth with a return of bookings growth can close the gap slowly through 2027 and 2028.
Next checkpoint: Full-year 2026 results and 2027 outlook (Jan 27, 2027 (estimate))
Well below intrinsic value · Analysts: Bullish
Corteva kept the old DuPont PFAS liabilities after the Vylor spin-off and states sued to stop it, so the gap closes slowly as courts and settlements limit the legal risk.
Next checkpoint: Q3 2026 results: first stand-alone report and outlook (Nov 11, 2026)
Well below intrinsic value · Analysts: Mixed
Falling revenue, repeated outlook cuts and new leaders hold Fiserv down, so growth must return in 2027 and stay on the path to its 2029 targets for the gap to close.
Next checkpoint: Full-year 2026 results and 2027 outlook (Feb 3, 2027 (estimate))
Well below intrinsic value · Analysts: Bullish
The market prices Freshpet for slower growth and new rivals in fresh pet food, and sales growth faster than the category with rising margins and cash flow can close the gap.
Next checkpoint: Q4 2026 results and 2027 outlook: growth and free cash flow (Feb 4, 2027 (estimate))
Well below intrinsic value · Analysts: Bullish
A sudden CEO change and a costly missile buildout make investors doubt L3Harris's growth plan, and steady guidance and a missile business IPO by the end of 2027 can close the gap.
Next checkpoint: Q4 2026 results and 2027 guidance (Jan 29, 2027 (estimate))
Well below intrinsic value · Analysts: Bullish
The market prices Mattel for lower margins from tariffs and a new CEO, and a holiday season that meets the lower 2026 guidance with a clear 2027 plan can close the gap.
Next checkpoint: 2027 guidance under the new CEO (Feb 5, 2027 (estimate))
Well below intrinsic value · Analysts: Leaning bullish
A sudden pool channel stock cut, a CFO exit and a debt-funded Taco deal broke trust in Pentair, so a Pool recovery in the 2027 season can close the gap.
Next checkpoint: Q4 2026 results and 2027 outlook (Jan 27, 2027 (estimate))
Well below intrinsic value · Analysts: Leaning bullish
The market fears that Sanofi depends on Dupixent with a weak pipeline, and new late-stage successes under the new CEO over 2027 and 2028 can close the gap slowly.
Next checkpoint: FY 2026 results and 2027 guidance (Jan 28, 2027)
Well below intrinsic value · Analysts: Bullish
The market fears that AI music and slower streaming will hurt Warner Music, and continued subscription growth with higher margins and lower debt can close the gap.
Next checkpoint: Fiscal 2026 results and fiscal 2027 outlook (Nov 19, 2026)
Below intrinsic value · Analysts: Leaning bullish
The market prices AGCO for a long farm equipment downturn after it cut its 2026 outlook, and a recovery in farm demand with lower dealer inventories in 2027 can close the gap.
Next checkpoint: Q4 2026 earnings: 2027 outlook (Jan 29, 2027 (estimate))
Below intrinsic value · Analysts: Very bullish
The market prices Aptar for lower margins and the drop in emergency medicine sales, and a margin recovery as destocking ends in late 2026 under the new CEO can close the gap.
Next checkpoint: Q4 2026 earnings: end of destocking (Jan 29, 2027 (estimate))
Below intrinsic value · Analysts: Leaning bullish
The market prices Gap for weak sales at Old Navy and Athleta and for tariff costs, and better Old Navy sales over the holidays with stable margins can close the gap.
Next checkpoint: Q3 fiscal 2026 results: Old Navy trend (Nov 19, 2026)
Below intrinsic value · Analysts: Leaning bullish
The market doubts that General Dynamics' submarine work can earn better margins, and higher Marine margins with steady Gulfstream deliveries over the next four to six quarters can close the gap.
Next checkpoint: Q4 2026 results and 2027 outlook, first under the new CEO (Jan 30, 2027 (estimate))
Below intrinsic value · Analysts: Bearish
The market prices General Mills for falling volume and lower profits in US packaged food, and stable organic sales with cost savings that protect earnings under the new CEO can close the gap.
Next checkpoint: Q2 fiscal 2027 results: volume and cost savings (Dec 23, 2026 (estimate))
Below intrinsic value · Analysts: Leaning bullish
The market prices Hexcel for a slow ramp of aircraft production and low margins, and steady rate increases at Airbus and Boeing that lift margins and cut debt can close the gap slowly.
Next checkpoint: Q4 2026 results and 2027 guidance (Jan 27, 2027 (estimate))
Below intrinsic value · Analysts: Mixed
The market prices Hormel for falling Retail volume and years of leadership changes, and a fiscal 2027 outlook with profit growth and a clean Brakebush close can close the gap.
Next checkpoint: Q4 fiscal 2026 results and the fiscal 2027 outlook (Nov 27, 2026 (estimate))
Below intrinsic value · Analysts: Mixed
The market prices Kilroy for low occupancy and high debt in West Coast offices, and only higher occupancy, new leases at Kilroy Oyster Point and stable debt over two to three years can close the gap.
Next checkpoint: Q4 2026 results and 2027 guidance (Jan 22, 2027 (estimate))
Below intrinsic value · Analysts: Mixed
The market doubts that Nestlé can grow volume without price increases while its debt is high, and only steady RIG growth and debt cuts over two to three years can close the gap.
Next checkpoint: Full-year 2026 results: margin, free cash flow and net debt (Feb 18, 2027)
Below intrinsic value · Analysts: Leaning bullish
Investors fear that AI shrinks agency work while Omnicom combines with IPG, so steady organic growth and the planned cost synergies must hold for years to close the gap.
Next checkpoint: Q4 2026 results: full-year synergies (Jan 22, 2027 (estimate))
Below intrinsic value · Analysts: Leaning bullish
The market doubts that Calvin Klein and TOMMY HILFIGER can grow while Europe and wholesale stay weak, and steady direct sales with a stable EMEA through 2027 can close the gap.
Next checkpoint: Q3 2026 earnings: EMEA and margin (Dec 2, 2026 (estimate))
Below intrinsic value · Analysts: Mixed
Investors fear that PayPal keeps losing branded checkout share to other wallets and AI agents, so only years of steady checkout growth under the new CEO can close the gap.
Next checkpoint: Q4 2026 results and 2027 outlook (Jan 27, 2027 (estimate))
Below intrinsic value · Analysts: Very bullish
The market doubts that Rentokil can make Terminix grow, and faster North America growth under the new CEO over 2027 and 2028 can close the gap.
Next checkpoint: FY 2026 results and the CEO's detailed plan (Feb 25, 2027)
Below intrinsic value · Analysts: Mixed
The market fears that AI search cuts the leads that bring Rollins new customers, and stable leads with faster organic growth over three to five quarters can close the gap.
Next checkpoint: Full-year 2026 results and 2027 framework (Jan 21, 2027 (estimate))
Below intrinsic value · Analysts: Mixed
The market prices Smith+Nephew for weak Orthopaedics growth and two cuts to its 2026 outlook, and growth from new knee and hip products in 2027 can close the gap over four to six quarters.
Next checkpoint: Full-year 2026 results and 2027 outlook (Mar 1, 2027)
Below intrinsic value · Analysts: Bullish
The market prices Sun Communities for weak RV results, past losses and high interest rates, and steady manufactured housing growth with good use of the UK sale proceeds can close the gap.
Next checkpoint: 2026 results and the 2027 guidance (Jan 26, 2027 (estimate))
Below intrinsic value · Analysts: Bullish
The market fears that SpaceX will become a fourth national carrier, and steady account growth, low churn and cash flow on guidance over two to three years can close the gap.
Next checkpoint: Q4 2026 results and 2027 guidance (Jan 28, 2027 (estimate))
Below intrinsic value · Analysts: Leaning bullish
The market prices TIM Brasil for the risks of Brazil and a new controlling shareholder, and steady service growth with high payouts can close the gap slowly over one to two years.
Next checkpoint: 2026 results, the 2027 plan and the shareholder payout (Feb 9, 2027 (estimate))
Below intrinsic value · Analysts: Leaning bullish
Tractor Supply's growth stalled and it withdrew its long-term targets, and steady comparable sales growth with a credible new framework over four to six quarters can close the gap.
Next checkpoint: Q4 2026 results and new long-term framework (Jan 22, 2027 (estimate))
Below intrinsic value · Analysts: Bullish
The market still prices UnitedHealth as a troubled business, and a low medical care ratio without reserve help and a mild result in the DOJ billing case can close the gap over two to four quarters.
Next checkpoint: 2027 earnings outlook (Dec 2026 (estimate))
Below intrinsic value · Analysts: Leaning bullish
The market prices Vivmark for slow rent growth and the risk of the AvalonBay and Equity Residential merger, and synergies on plan with better rent growth in 2027 can close the gap.
Next checkpoint: 2027 guidance: synergies and rent growth (Feb 4, 2027 (estimate))
Below intrinsic value · Analysts: Mixed
Investors doubt that Zimmer Biomet can grow with its market while knee sales fall and leaders change, and better knee sales and organic growth over four to six quarters can close the gap.
Next checkpoint: Full-year 2026 results and 2027 guidance (Feb 4, 2027 (estimate))
Close to intrinsic value · Analysts: Leaning bullish
The market prices Align for slow growth and pressure from cheaper aligners, and steady volume growth with savings from the review pushed by Elliott can close the gap over three to six quarters.
Next checkpoint: Q4 2026 results, the operating model review and the new CEO's plan (Jan 28, 2027 (estimate))
Close to intrinsic value · Analysts: Leaning bullish
The market prices Amrize for higher energy costs, a cut to its 2026 guidance and many changes of finance leaders, and better price against cost with no more guidance cuts over four to six quarters can close the gap.
Next checkpoint: Full-year 2026 results and 2027 guidance (Jan 28, 2027 (estimate))
Close to intrinsic value · Analysts: Leaning bullish
The market prices Aon for the debt and risk of its $17 billion USI purchase and a pause in buybacks, and a clean close in Q4 2026 with steady organic growth and debt repayment can close the gap.
Next checkpoint: USI purchase closes (Q4 2026 (estimate))
Close to intrinsic value · Analysts: Leaning bullish
The market doubts that BP can keep its 2026 cash flow when oil prices and refining margins fall, and lower debt with a clear plan from the December 2026 update can close the gap within one to two years.
Next checkpoint: Strategy and outlook update (Dec 15, 2026)
Close to intrinsic value · Analysts: Bearish
The market fears that people will drink less spirits for many years, and a return to organic sales growth under a new CEO can close the gap only slowly.
Next checkpoint: Q2 fiscal 2027 results: organic sales trend (Dec 2, 2026 (estimate))
Close to intrinsic value · Analysts: Leaning bullish
The market prices Brunswick for weak boat demand from cautious buyers and high rates, and a recovery in retail demand with steady engine and parts sales in 2027 can close the gap.
Next checkpoint: Full-year 2026 report and 2027 outlook (Jan 29, 2027 (estimate))
Close to intrinsic value · Analysts: Mixed
The market fears that AI will lower demand for CGI's IT services and prices it for slow growth, and faster organic growth from its backlog with steady margins can close the gap over four to six quarters.
Next checkpoint: Q4 fiscal 2026 results: growth and bookings (Nov 11, 2026)
Close to intrinsic value · Analysts: Leaning bullish
The market fears that CME Group's record trading volume falls when markets calm down, and steady volume with growing market data revenue through 2027 can close the gap.
Next checkpoint: Q4 2026 results and annual variable dividend (Feb 3, 2027 (estimate))
Close to intrinsic value · Analysts: Bearish
The market prices Choice Hotels for flat US hotel demand and a change of CEO, and a return to US room growth with steady fees over the next four to six quarters can close the gap.
Next checkpoint: Q4 2026 results and 2027 outlook (Feb 2, 2027 (estimate))
Close to intrinsic value · Analysts: Bullish
The market doubts that ConocoPhillips can keep its 2026 earnings when oil prices fall, and steady cash returns with Willow on schedule for the free cash flow rise by 2029 can close the gap.
Next checkpoint: Close of the Kirkuk joint venture purchase (Q4 2026 (estimate))
Close to intrinsic value · Analysts: Bullish
Investors fear that cheap AI tools can copy Constellation's niche software, and only a recovery in organic growth and good acquisitions under the new President over several years can close the gap.
Next checkpoint: Full-year 2026 results and first annual letter under Miller (Feb 6, 2027 (estimate))
Close to intrinsic value · Analysts: Bullish
The market fears that the loss of one large insurance customer starts a bigger shift, and stable car volumes by mid-2027 can close the gap.
Next checkpoint: Q1 FY2027 results: unit volume and operating margin (Nov 19, 2026 (estimate))
Close to intrinsic value · Analysts: Very bullish
The market doubts that Danaher's slow growth will recover while it absorbs Masimo under a new CEO, and a mid-single-digit core growth rate in 2027 can close the gap.
Next checkpoint: Q4 2026 results and 2027 guidance (Jan 21, 2027 (estimate))
Close to intrinsic value · Analysts: Bullish
Investors expect cable decline and sports costs to cut Disney's profit, and steady parks growth with a rising streaming margin over the next four to six quarters can close the gap.
Next checkpoint: Fiscal 2026 results and fiscal 2027 outlook (Nov 17, 2026)
Close to intrinsic value · Analysts: Leaning bullish
US sales have almost stopped growing and franchisees open fewer stores, and a return to low-single-digit US sales growth in 2027 can close the gap.
Next checkpoint: Q4 2026 results and 2027 outlook (Feb 22, 2027 (estimate))
Close to intrinsic value · Analysts: Leaning bullish
The market prices Extra Space for a slow recovery in storage demand while few people move, and same-store revenue growth that keeps rising into 2027 under the new CEO can close the gap.
Next checkpoint: Q4 2026 results and 2027 guidance: first outlook under the new CEO (Jan 27, 2027 (estimate))
Close to intrinsic value · Analysts: Leaning bullish
A weak housing market and a new leadership team hold Fortune Brands down, so sales must grow again and margins must rise without one-time tariff and tax gains for the gap to close.
Next checkpoint: Fiberon sale closes (Dec 2026 (estimate))
Close to intrinsic value · Analysts: Bullish
Cost inflation, China and a weak monitoring unit hold GE HealthCare's profit back, and higher margins and cash from its large backlog over the next four to six quarters can close the gap.
Next checkpoint: Q4 2026 results and 2027 outlook (Jan 28, 2027 (estimate))
Close to intrinsic value · Analysts: Leaning bullish
Investors pay a premium for JPMorgan's high and steady returns, and returns that stay high when trading slows and credit losses rise can earn it.
Next checkpoint: Q4 2026 results and 2027 guidance (Jan 14, 2027)
Close to intrinsic value · Analysts: Leaning bullish
The market prices KT for low returns, a security incident and large investment plans, and higher margins with buybacks toward the 2028 value-up targets can close the gap slowly.
Next checkpoint: Q3 2026 results: wireless recovery (Nov 10, 2026)
Close to intrinsic value · Analysts: Leaning bullish
The market fears that Kimberly-Clark paid too much for Kenvue while its own sales are weak, and a return to sales growth with synergies and debt reduction in 2027 can close the gap.
Next checkpoint: Q4 2026 results and 2027 outlook of the combined company (Feb 5, 2027 (estimate))
Close to intrinsic value · Analysts: Bearish
The market prices Markel for uneven profits outside its insurance business, and a steady combined ratio with no new State National losses over the next four to six quarters can close the gap.
Next checkpoint: 2026 annual results: adjusted operating income (Jan 28, 2027 (estimate))
Close to intrinsic value · Analysts: Mixed
The market fears that Novo is losing the obesity-drug race to Lilly, and a CagriSema approval in Q4 2026 with more Wegovy pill growth can close the gap.
Next checkpoint: FDA decision on CagriSema for obesity (Q4 2026 (estimate))
Close to intrinsic value · Analysts: Leaning bullish
Investors fear that the pool-building boom is over, but steady maintenance demand and a smooth CEO change over the next two to four quarters can close the gap.
Next checkpoint: Full-year 2026 results and first 2027 outlook from new CEO (Jan 22, 2027 (estimate))
Close to intrinsic value · Analysts: Mixed
QIAGEN now trades on a pending EUR 46.50 per share cash offer from EQT, and tender acceptance, the shareholder vote and regulatory clearances before a close in mid-2027 decide the outcome.
Next checkpoint: Extraordinary General Meeting: new CEO (Nov 6, 2026)
Close to intrinsic value · Analysts: Very bullish
The market prices RB Global for lower fees per sale and higher debt, and a stable take rate with growth in 2027 and lower leverage can close the gap over three to five quarters.
Next checkpoint: Full-year 2026 results and 2027 outlook (Feb 9, 2027 (estimate))
Close to intrinsic value · Analysts: Leaning bullish
The market prices Simon like other REITs that move with interest rates and doubts its new CEO, and steady NOI growth with stable rates and disciplined leadership can close the gap.
Next checkpoint: 2027 guidance under the new CEO (Feb 5, 2027 (estimate))
Close to intrinsic value · Analysts: Bullish
Stryker cut its 2026 outlook after slow hip, knee and clot removal sales, and a return to strong growth in the 2027 outlook over three to five quarters can close the gap.
Next checkpoint: Q4 2026 results and 2027 outlook under the new CEO (Jan 29, 2027 (estimate))
Close to intrinsic value · Analysts: Mixed
The market prices CooperCompanies for slow contact lens growth after a strategic review that kept CooperSurgical, and a return to CooperVision growth in fiscal 2027 can close the gap.
Next checkpoint: Q4 fiscal 2026 earnings and fiscal 2027 guidance (Dec 9, 2026 (estimate))
Close to intrinsic value · Analysts: Bullish
The market prices TransUnion for changes in US mortgage credit scoring, the credit cycle and its debt, and steady organic growth with lower leverage over three to five quarters can close the gap.
Next checkpoint: 2026 results and the 2027 guidance (Jan 27, 2027 (estimate))
Close to intrinsic value · Analysts: Mixed
The market prices Truist for returns below its best peers and the uncertainty of a new CEO's review, and higher returns after the loan sales over four to six quarters can close the gap.
Next checkpoint: LightStream sale closes (Q4 2026 (estimate))
Close to intrinsic value · Analysts: Bullish
The market prices Weatherford for lower activity in the Middle East after the Iran conflict, and a gradual recovery with strong free cash flow and the move to Delaware can close the gap.
Next checkpoint: Redomestication to Delaware closes (Nov 13, 2026)
Close to intrinsic value · Analysts: Leaning bullish
The market fears that the 2026 World Cup year is a peak for adidas, and steady growth in 2027 with a recovery in footwear can close the gap.
Next checkpoint: Full-year 2026 results and 2027 outlook (Jan 29, 2027 (estimate))
Pricey · Analysts: Bullish
The market questions Healthcare Solutions growth and savings and two leadership changes, and the next two to four quarters show if both stay on track.
Next checkpoint: John Morris becomes CEO (Jan 4, 2027)
Far above intrinsic value · Analysts: Leaning bullish
Investors pay a premium for Berkshire's safety and its large cash balance, and only years of good use of that cash by Greg Abel, as interest income falls, can earn it.
Next checkpoint: Full-year 2026 results and annual letter (Feb 27, 2027 (estimate))
Far above intrinsic value · Analysts: Bullish
Investors pay a premium for the fast margin recovery at CSX under its new chief executive, and only higher margins, volume growth and better service through 2027 can earn it.
Next checkpoint: Q4 2026 results and 2027 outlook (Jan 21, 2027 (estimate))
Far above intrinsic value · Analysts: Leaning bullish
The market fears that AI tools cut the engineering hours that clients buy from EPAM, and growth that moves up again in 2027 with stable margins can close the gap.
Next checkpoint: 2027 outlook: does growth move up again (Feb 5, 2027 (estimate))
Far above intrinsic value (AI estimate) · Analysts: Very bullish
HDFC Bank trades at a premium to the AI estimate because investors pay for its long growth record, and higher returns with no new governance problems under its new leaders can earn it.
Next checkpoint: Q3 fiscal 2027 results: profit growth and margin (Jan 16, 2027 (estimate))
Far above intrinsic value · Analysts: Bullish
Investors pay a premium for Thermo Fisher's scale and steady growth, and only faster organic growth with lower debt after the Clario purchase can earn it over several years.
Next checkpoint: Q4 2026 results and 2027 guidance (Feb 2, 2027 (estimate))
Far above intrinsic value · Analysts: Leaning bullish
A large outbreak at Taco Bell and higher rates hold the price down, and positive Taco Bell US sales growth by Q1 2027 can close the gap.
Next checkpoint: Q4 2026 results: Taco Bell US sales trend (Feb 3, 2027 (estimate))
Pass rate counts thesis checkpoints that came true. It is not an investment return. Past results do not predict future results.
Every result is on the checkpoints page.
Picks gives general opinions about stocks, including a "Top pick" label. They are not tailored to your needs, goals or risk tolerance. Kevin is not a registered adviser and relies on the general-advice exemption in Canadian securities law (NI 31-103 s.8.25). Do your own research, or ask a registered adviser. Kevin may hold any stock on this site. Read the Disclaimer.